Mark Greathouse

Summary

Country: USA

Publications

  1. doi request reprint Olmesartan medoxomil-based therapy for the management of hypertension
    Mark Greathouse
    South Hills Cardiology Associates, 2000 Oxford Drive, Ste 680, Bethel Park, Pittsburgh, PA 15102, USA
    Expert Rev Clin Pharmacol 1:593-604. 2008
  2. doi request reprint The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications
    Mark K Greathouse
    South Hills Cardiology Associates of Pittsburgh, PA, USA
    Postgrad Med 124:40-52. 2012
  3. ncbi request reprint A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations?
    Mark Greathouse
    Program for the Prevention of Heart Disease, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA
    Congest Heart Fail 8:313-20. 2002
  4. pmc Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
    Mark Greathouse
    South Hills Cardiology Associates of Pittsburgh, Pittsburgh, PA, USA
    Vasc Health Risk Manag 2:401-9. 2006
  5. doi request reprint Nebivolol efficacy and safety in patients with stage I-II hypertension
    Mark Greathouse
    South Hill Cardiology Associates, St Clair Memorial Hospital, Pittsburgh, Pennsylvania, USA
    Clin Cardiol 33:E20-7. 2010

Collaborators

Detail Information

Publications5

  1. doi request reprint Olmesartan medoxomil-based therapy for the management of hypertension
    Mark Greathouse
    South Hills Cardiology Associates, 2000 Oxford Drive, Ste 680, Bethel Park, Pittsburgh, PA 15102, USA
    Expert Rev Clin Pharmacol 1:593-604. 2008
    ..This review evaluates the chemistry, efficacy and safety of olmesartan medoxomil-based therapy and its expanding role in hypertension management. ..
  2. doi request reprint The role of ARBs alone or with HCTZ in the treatment of hypertension and prevention of cardiovascular and renal complications
    Mark K Greathouse
    South Hills Cardiology Associates of Pittsburgh, PA, USA
    Postgrad Med 124:40-52. 2012
    ..Hypertension (HTN) management guidelines stress the importance of effective blood pressure (BP) control to prevent progression to adverse cardiovascular (CV) and renal outcomes...
  3. ncbi request reprint A review of olmesartan medoxomil monotherapy: antihypertensive efficacy similar to that of other angiotensin II receptor blocker/hydrochlorothiazide combinations?
    Mark Greathouse
    Program for the Prevention of Heart Disease, Allegheny General Hospital, West Penn Allegheny Health System, Pittsburgh, PA, USA
    Congest Heart Fail 8:313-20. 2002
    ..These comparisons may have important clinical implications regarding the optimal choice of first-line antihypertensive therapy...
  4. pmc Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
    Mark Greathouse
    South Hills Cardiology Associates of Pittsburgh, Pittsburgh, PA, USA
    Vasc Health Risk Manag 2:401-9. 2006
    ..In conclusion, olmesartan medoxomil/HCTZ is an effective and well-tolerated combination antihypertensive therapy that results in significant BP reductions and BP control in many patients...
  5. doi request reprint Nebivolol efficacy and safety in patients with stage I-II hypertension
    Mark Greathouse
    South Hill Cardiology Associates, St Clair Memorial Hospital, Pittsburgh, Pennsylvania, USA
    Clin Cardiol 33:E20-7. 2010
    ..Nebivolol is a novel, beta(1)-adrenergic receptor blocker with vasodilatory properties mediated through activation of the L-arginine/nitric oxide pathway...